CEREBRUM

Serial Number 97979637
807

Registration Progress

Application Filed
Feb 7, 2023
Under Examination
Jun 4, 2024
Approved for Publication
Oct 17, 2023
Published for Opposition
Oct 17, 2023
Registered

Trademark Image

CEREBRUM

Basic Information

Serial Number
97979637
Filing Date
February 7, 2023
Published for Opposition
October 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
807
Status Date
Mar 19, 2025
Application
Pending
Classes
042 044

Rights Holder

Praxis Precision Medicines, Inc.

03
Address
99 High Street, 30th Floor
Boston, MA 02110

Ownership History

Praxis Precision Medicines, Inc.

Original Applicant
03
Boston, MA

Praxis Precision Medicines, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Michael H. Jacobs

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description Documents
Jun 18, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jun 18, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Mar 21, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 21, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 21, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 19, 2025 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 19, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 19, 2025 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Mar 18, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 19, 2025 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Feb 11, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 27, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 27, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Nov 27, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Nov 27, 2024 IUAF S USE AMENDMENT FILED Loading...
Jun 4, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 25, 2024 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Apr 5, 2024 CHPB I POST PUBLICATION AMENDMENT - ENTERED Loading...
Apr 2, 2024 APET A ASSIGNED TO PETITION STAFF Loading...
Feb 28, 2024 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Nov 13, 2023 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 8, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 7, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 7, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Sep 7, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 7, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 5, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 27, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 10, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing medical and scientific research information in the field of pharmaceutical research for the treatment of neurological disorders and central nervous system disorders
First Use Anywhere: Feb 6, 2023
First Use in Commerce: Feb 6, 2023
Class 044
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals for the treatment of neurological disorders and central nervous system disorders; providing information in the field of treatment of neurological disorders and central nervous system disorders; consulting services in the field of pharmaceuticals for the treatment of neurological disorders and central nervous system disorders
First Use Anywhere: Feb 6, 2023
First Use in Commerce: Feb 6, 2023

Classification

International Classes
042 044